Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5168)
All Articles published online
|
Aug 7, 2011 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shu Y, Wang B, Wang J, Wang JM, Zou SQ. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma. World J Gastroenterol 2011; 17(29): 3407-3419 [PMID: 21876633 DOI: 10.3748/wjg.v17.i29.3407] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i29/3407.htm |
| Number | Citing Articles |
| 1 |
HYE-RIM PARK, WOON-WON JUNG, HYUN-SOOK KIM, YONG-KOO PARK. Microarray-based DNA methylation study of Ewing’s sarcoma of the bone. Oncology Letters 2014; 8(4): 1613 doi: 10.3892/ol.2014.2322
|
| 2 |
Laura-Kim Feiner, Sascha Tierling, Sebastian Holländer, Matthias Glanemann, Claudia Rubie. An aging and p53 related marker: HOXA5 promoter methylation negatively correlates with mRNA and protein expression in old age. Aging 2021; 13(4): 4831 doi: 10.18632/aging.202621
|
| 3 |
Zhen-Huan Ma, Yong Yang, Lei Zou, Kai-Yuan Luo. 125I seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric cancer xenografts. Journal of Experimental & Clinical Cancer Research 2012; 31(1) doi: 10.1186/1756-9966-31-61
|
| 4 |
Colm J. O’Rourke, Letizia Satriano, Douglas V.N.P. Oliveira, Patricia Munoz-Garrido, Jesper B. Andersen. Pharmacoepigenetics. 2019; : 551 doi: 10.1016/B978-0-12-813939-4.00017-6
|
| 5 |
Colm J. O'Rourke, Patricia Munoz-Garrido, Esmeralda L. Aguayo, Jesper B. Andersen. Epigenome dysregulation in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1423 doi: 10.1016/j.bbadis.2017.06.014
|
| 6 |
Qiao Wu, Chang-Zheng Liu, Lian-Yuan Tao, Lan Yu, Wei Liu, Song-Sen Chen, Xiao-Dong He. The Clinicopathological and Prognostic Impact of 14-3-3 Protein Isoforms Expression in Human Cholangiocarcinoma by Immunohistochemistry. Asian Pacific Journal of Cancer Prevention 2012; 13(4): 1253 doi: 10.7314/APJCP.2012.13.4.1253
|
| 7 |
Flávia Caló Aquino Xavier, Maria Fernanda de Souza Setubal Destro, Carina Magalhães Esteves Duarte, Fabio Daumas Nunes. Epigenetic repression of HOXB cluster in oral cancer cell lines. Archives of Oral Biology 2014; 59(8): 783 doi: 10.1016/j.archoralbio.2014.05.001
|
| 8 |
V. Branchi, P. Schaefer, A. Semaan, A. Kania, P. Lingohr, J. C. Kalff, N. Schäfer, G. Kristiansen, D. Dietrich, H. Matthaei. Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0299-x
|
| 9 |
Ana Paço, Simone Aparecida de Bessa Garcia, Renata Freitas. Methylation in HOX Clusters and Its Applications in Cancer Therapy. Cells 2020; 9(7): 1613 doi: 10.3390/cells9071613
|
| 10 |
Hemapreethi Surendran, Thirunavukkarasu Palaniyandi, Sudhakar Natarajan, Rajeswary Hari, Sandhiya Viwanathan, Gomathy Baskar, Mugip Rahaman Abdul Wahab, Maddaly Ravi, Barani Kumar Rajendran. Role of homeobox d10 gene targeted signaling pathways in cancers. Pathology - Research and Practice 2023; 248: 154643 doi: 10.1016/j.prp.2023.154643
|
| 11 |
Rocio I.R. Macias, Jesus M. Banales, Bruno Sangro, Jordi Muntané, Matias A. Avila, Elisa Lozano, Maria J. Perugorria, Francisco J. Padillo, Luis Bujanda, Jose J.G. Marin. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1468 doi: 10.1016/j.bbadis.2017.08.002
|
| 12 |
Veronika Vymetalkova, Pavel Vodicka, Barbara Pardini, Fabio Rosa, Miroslav Levy, Michaela Schneiderova, Vaclav Liska, Ludmila Vodickova, Torbjörn K Nilsson, Sanja A Farkas. Epigenome-Wide Analysis of DNA Methylation Reveals a Rectal Cancer-Specific Epigenomic Signature. Epigenomics 2016; 8(9): 1193 doi: 10.2217/epi-2016-0044
|
| 13 |
Margherita Rimini, Marco Puzzoni, Federica Pedica, Nicola Silvestris, Lorenzo Fornaro, Giuseppe Aprile, Eleonora Loi, Oronzo Brunetti, Caterina Vivaldi, Francesca Simionato, Patrizia Zavattari, Mario Scartozzi, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini. Cholangiocarcinoma: new perspectives for new horizons. Expert Review of Gastroenterology & Hepatology 2021; 15(12): 1367 doi: 10.1080/17474124.2021.1991313
|
| 14 |
Bo-Wei Han, Hua Ye, Pan-Pan Wei, Bo He, Cai Han, Zhen-Hua Chen, Yue-Qin Chen, Wen-Tao Wang. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-5133-8
|
| 15 |
Xiang-Yong Hao, An-Qiang Li, Hao Shi, Tian-Kang Guo, Yan-Fei Shen, Yuan Deng, Li-Tian Wang, Tao Wang, Hui Cai. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma. Bioscience Reports 2021; 41(3) doi: 10.1042/BSR20203945
|
| 16 |
Hironori Yamashita, Aikaterini Tourna, Masayuki Akita, Tomoo Itoh, Shilpa Chokshi, Tetsuo Ajiki, Takumi Fukumoto, Neil A. Youngson, Yoh Zen. Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma. Virchows Archiv 2022; 480(5): 1077 doi: 10.1007/s00428-021-03251-x
|
| 17 |
Matthew A. Cooley, Amber R. Schneider, Emily G. Barr Fritcher, Dragana Milosevic, Michael J. Levy, Amber R. Bridgeman, John A. Martin, Bret T. Petersen, Barham K. Abu Dayyeh, Andrew C. Storm, Ryan J. Law, Eric J. Vargas, Vishal Garimella, Tyler Zemla, Sarah M. Jenkins, Jun Yin, Gregory J. Gores, Lewis R. Roberts, Benjamin R. Kipp, Vinay Chandrasekhara. Utility of methylated DNA markers for the diagnosis of malignant biliary strictures. Hepatology 2024; doi: 10.1097/HEP.0000000000000970
|
| 18 |
Jing Shen, Shuang Wang, Yu-Jing Zhang, Maya A. Kappil, Hui-Chen Wu, Muhammad G. Kibriya, Qiao Wang, Farzana Jasmine, Habibul Ahsan, Po-Huang Lee, Ming-Whei Yu, Chien-Jen Chen, Regina M. Santella. Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma. Epigenetics 2012; 7(11): 1230 doi: 10.4161/epi.22140
|
| 19 |
Eleonora Loi, Cesare Zavattari, Alessandro Tommasi, Loredana Moi, Matteo Canale, Agnese Po, Claudia Sabato, Ana Florencia Vega-Benedetti, Pina Ziranu, Marco Puzzoni, Eleonora Lai, Luca Faloppi, María Rullán, Juan Carrascosa, Irene Amat, Jesús M. Urman, Maria Arechederra, Carmen Berasain, Elisabetta Ferretti, Andrea Casadei-Gardini, Matías A. Avila, Sergio Alonso, Mario Scartozzi, Patrizia Zavattari. HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples. British Journal of Cancer 2022; 126(12): 1783 doi: 10.1038/s41416-022-01738-1
|
| 20 |
Müjdat Zeybel, Sezgin Vatansever, Timothy Hardy, Ayşegül Akder Sarı, Fulya Cakalağaoğlu, Arzu Avcı, Gemma Louise Zeybel, Serçin Karahüseyinoğlu, Matthew Bashton, John C. Mathers, Belkıs Ünsal, Jelena Mann. DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease. Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0218-1
|
| 21 |
Colm J. O’Rourke, Juan Lafuente-Barquero, Jesper B. Andersen. Epigenome Remodeling in Cholangiocarcinoma. Trends in Cancer 2019; 5(6): 335 doi: 10.1016/j.trecan.2019.05.002
|
| 22 |
Kazuaki Nakamura, Kazuhiko Nakabayashi, Kyaw Htet Aung, Kazuko Aizawa, Naoko Hori, Junji Yamauchi, Kenichiro Hata, Akito Tanoue, Diego Calvisi. DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status. PLOS ONE 2015; 10(3): e0120545 doi: 10.1371/journal.pone.0120545
|
| 23 |
Liankui Han, Gang Xu, Chuan Xu, Bo Liu, Di Liu. Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.7790
|